Tuesday, June 14, 2016

New Study Finds a 16% Reduction in Cardiovascular Events with the Use of ACEIs and ARBs

Two classes of blood pressure medications, angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs), are associated with a 16% lower risk of strokes, heart attacks and death in patients with end-stage renal disease who are undergoing peritoneal dialysis, a new study in the journal, Nephrology Dialysis Transplantation, reports.

Monday, June 6, 2016

They Find Study “Reassuring” and Say it Has Lessons for Cardiologists and Oncologists

In an editorial in the New England Journal of Medicine, LA BioMed Researchers Rowan T. Chlebowski, MD, PhD, and Matthew J. Budoff, MD, said a new study of the long-term use of aromatase inhibitors to prevent the recurrence of certain types of breast cancer is “reassuring,” and they urged oncologists and cardiologists to combine prevention and early detection to prevent disease.

Tuesday, May 31, 2016

The National Institute of Neurological Disorders and Stroke recently awarded over $1.7 million in grant funding to Phoenix Nest, Inc. to continue its partnership with the Los Angeles Biomedical Institute (LA BioMed) to research the development of therapies for treating different forms of a devastating inherited genetic disorder, Sanfilippo disease, also known as MPS III.

Tuesday, May 31, 2016

Patients with diabetic ketoacidosis (DKA) face a much higher risk of succumbing to a deadly fungal infection, known as mucormycosis, than healthy patients. A new study suggests a simple treatment of sodium bicarbonate, or baking soda, could prevent the spread of mucormycosis in patients with DKA. 

Friday, April 15, 2016

New Data from Women’s Health Initiative Dietary Modification Trial Finds Long-term Dietary Changes Improves Breast Cancer Survival Rates

Women who stayed on a low fat diet for approximately eight years reduced their risk of death from invasive breast cancers and improved their survival rates when compared with women who had not followed the dietary regimen, according to a study presented at a clinical trial plenary session, entitled "Transformative Clinical Trials in Breast Cancer," at the American Association for Cancer Research (AACR) annual meeting.

Wednesday, April 13, 2016

LA BioMed is the first and only Los Angeles facility to offer CT scans on the new GE  Heathcare’s Revolution* CT scanner, which makes it possible for the institute’s physicians to diagnose even the most challenging patients, at the lowest radiation doses available in the industry.  

Monday, March 28, 2016

In the first study of its kind, researchers found patients with S. aureus skin and soft tissue infections took, on average, just 57% of their prescribed antibiotic doses after leaving the hospital, resulting in nearly half of them getting a new infection or needing additional treatment for the existing skin infection.

Tuesday, March 1, 2016

Data on Injuries and Mental Abilities Combined to Determine the Potential for Cognitive Deficits

LOS ANGELES (March 1, 2016) – Amid the heightened awareness of concussion-related brain damage among professional football players, a new study reports that researchers can predict cognitive outcomes  long after the players have retired by reviewing the players’ concussion histories, game-related data and their overall mental abilities.

Wednesday, February 17, 2016

The TTrials Reveal Benefits of Testosterone Treatment for Older Men with Low Testosterone Levels

As men age, their testosterone levels decrease, but prior studies of the effects of administering testosterone to older men have been inconclusive. Now, research shows that testosterone treatment for men over 65 improves sexual function, walking ability and mood, according to a study published in the New England Journal of Medicine by a team of researchers that included lead researchers from Los Angeles Biomedical Research Institute (LA BioMed).

Wednesday, February 3, 2016

Three exemplary champions of LA BioMed, whose contributions continue to fuel discoveries that hold promise for patients around the globe, will be honored with Spirit of Excellence Awards at the nonprofit research institute’s 2016 Gala on May 5 at the Millennium Biltmore Hotel in downtown Los Angeles.